About Melior Discovery
Melior Discovery is a Healthcare company based in Exton (United States) founded in 2005. Pharmacology platform is developed to identify pre-clinical drug candidates. Melior Discovery has raised $3.32 million across 6 funding rounds from investors including HHS, The Michael J. Fox Foundation and BioAdvance. The company has 28 employees. Melior Discovery offers products and services including In Vivo Disease Models, thera TRACE Platform, opioid TRACE Platform, and immuno-thera TRACE Platform. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its competitors include Insitro, Avidity Biosciences and Certara; 2 of its 3 listed competitors have raised funding.
Company details
Melior Discovery was founded in 2005 and is based in Exton, United States. A vivo pharmacology platform named theraTRACE is utilized to uncover novel indications for pre-clinical and development-stage drugs. Services encompass therapeutic area evaluations, pharmacokinetic assessments, and efficacy modeling. The platform supports multinational pharmaceutical firms and biotech startups, with partnerships including Pfizer, Merck, AstraZeneca, and Johnson Johnson.
- Headquarters Exton, United States
- Employees 28
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website meliordiscovery.com
- Social LinkedIn X Facebook
- Total Equity Funding$3.32M (USD)
in 6 rounds
- Latest Funding Round$224.98K (USD), Grant
Sep 2014
- InvestorsHHS
& 2 more
- Employee Count28
Products & Services of Melior Discovery
Melior Discovery offers a comprehensive portfolio of products and services, including In Vivo Disease Models, thera TRACE Platform, opioid TRACE Platform, and immuno-thera TRACE Platform.
Validated animal models for testing drugs in various therapeutic areas
Tool for drug repositioning and efficacy screening in vivo
Platform for evaluating opioid-related drug effects
Screening tool for immunology and inflammation studies
Funding Insights of Melior Discovery
Melior Discovery has successfully raised a total of $3.32M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $224.98 thousand completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.32M
- Total Rounds 6
- Last Round Grant — $224,981
- First Round $500,000
(Jan 2005)
- Investors Count 3
All 6 funding rounds of Melior Discovery with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2014 | $224,981 | Grant | – | – | |
| Feb 2013 | $1.74M | Seed | – | – | – |
| Aug 2011 | Grant | – | – | ||
| Sep 2009 | $825,000 | Seed | – | – | – |
| Jul 2009 | $250,000 | Seed | – | – | – |
| Jan 2005 | $500,000 | Seed | – | – |
3 investors in total: 3 institutional.
Investors in Melior Discovery
Melior Discovery has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, The Michael J. Fox Foundation and BioAdvance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| bioadvance.com | ||||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Research for Parkinson's disease is funded by the foundation. | 2000 | michaeljfox.org | New York, United States |
Investor details for Melior Discovery
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Melior Discovery
12 people are tracked at Melior Discovery (8 in leadership, 4 in team); the tracked headcount is 28.
| Name | Role | Group |
|---|---|---|
Mahen Gundecha | Chief Business Officer | Leadership |
Andrew G. Reaume | President & CEO, Co-Founder | Leadership |
Vivian Cong | Head of Cardiovascular & Metabolic Diseases | Leadership |
Patty Ferrante | COO | Leadership |
Karla Kretschmannova | Director of Neuroscience | Leadership |
Amy DiCamillo | Senior Director of Behavioral & Pain Pharmacology | Leadership |
Vivian Cong (weina) | VP Of Research And Development | Leadership |
Hongyan Li | Director of Oncology | Leadership |
Bob Bendesky | Research Associate | Team |
Yang Y. | Senior Research Associate/project Coordinator | Team |
Entela Kapaj | Research Associate | Team |
Alexander Ochman | Sr Scientist Group Leader Research | Team |
Complete people profiles for Melior Discovery
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Melior Discovery
3 dated milestones of Melior Discovery across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Melior Discovery is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Grant, of $225K.
Competitors of Melior Discovery
Melior Discovery has 3 listed competitors in our database, 2 of them funded. They include Insitro, Avidity Biosciences and Certara.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| insitro.com | 2018 | San Francisco, United States | $643.21M | 257 | An AI-enabled platform is developed for infectious disease treatment. | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| certara.com | 2008 | Princeton, United States | 827 | Provider of a platform for in silico drug discovery and consulting services |
Detailed competitors of Melior Discovery
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Melior Discovery
The website of Melior Discovery (meliordiscovery.com) receives about 3.6K visits a month and ranks #3,218,060 among all websites worldwide, #4,229 in Biotechnology and Pharmaceuticals.
- Monthly visits3.6K
▼ 44.1% vs previous month
- Unique visitors2.9K
per month
- Global rank#3,218,060
among all websites
- Category rank#4,229
Health · Biotechnology and Pharmaceuticals
- Bounce rate43%
- Pages per visit1.5
- Average visit8 sec
- DevicesDesktop 33% · Mobile 67%
Websites whose visitors overlap most with Melior Discovery. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| drugdiscoverynews.com | 100% | #639,360 | View details | ||
| drugdiscoveryonline.com | 99% | #3,490,219 | View details | ||
| wuxiapptec.com | 99% | 107.6K | #296,852 | View details | |
| biomodels.com | 98% | 2.5K | #9,156,523 | View details | |
| washingtonbiotech.com | 98% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Melior Discovery
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Melior Discovery (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Melior Discovery
Complete news archive for Melior Discovery
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Melior Discovery
Melior Discovery was founded in 2005.
Melior Discovery is headquartered in Exton, United States. It is registered at Exton, Pennsylvania, United States.
Melior Discovery is a funded company, having raised a total of $3.32M across 6 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Jan 2005.
Melior Discovery has 28 employees.
Melior Discovery was founded in 2005 and is based in Exton, United States. A vivo pharmacology platform named theraTRACE is utilized to uncover novel indications for pre-clinical and development-stage drugs. Services encompass therapeutic area evaluations, pharmacokinetic assessments, and efficacy modeling. The platform supports multinational pharmaceutical firms and biotech startups, with partnerships including Pfizer, Merck, AstraZeneca, and Johnson Johnson.
Melior Discovery's top competitors include Insitro, Avidity Biosciences and Certara.
Melior Discovery offers In Vivo Disease Models, thera TRACE Platform, opioid TRACE Platform, and immuno-thera TRACE Platform.
Melior Discovery has 3 investors. Key investors include HHS, The Michael J. Fox Foundation, and BioAdvance.